Linde logo

Linde

LINDEINDIA NSE

Key Fundamentals

MidcapIndustrial GasesChemicals
Market Cap
₹52,949 Cr
Volatility
Low Risk
P/E Ratio
96.78
EBITDA
₹927 Cr
Return on Equity
12.87%
Debt to Equity
0.02
Book Value
₹500.3
EPS
₹52.52
52W High
₹8,049
52W Low
₹5,673

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 21.8%

Weaknesses

3
  • Stock is trading at 12.6 times its book value
  • The company has delivered a poor sales growth of 11.5% over past five years.
  • Company has a low return on equity of 13.0% over last 3 years.

Growth Rate

Revenue Growth
-0.17% higher than 3Y
Net Income Growth
20.71% higher than 3Y
Cash Flow Change
34.6% lower than 3Y
ROE
8.06% lower than 3Y
ROCE
7.17% higher than 3Y
EBITDA Margin (Avg.)
11.53% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk high

Linde India Ltd, with a market cap of ₹52,949 Cr, is a nearly debt-free industrial gases company trading at a PE of 97.2x and 12.45x book value. The company has delivered strong 10-year profit CAGR of 41% but revenue growth has been modest at 5% over the same period, with 3-year sales CAGR turning negative at -7%.

Bull Case 8
  • Company is almost debt free, providing strong balance sheet resilience and financial flexibility in a capital-intensive chemicals sector
  • Exceptional long-term profit compounding with 10-year compounded profit growth of 41%, indicating significant margin expansion and operational leverage
  • TTM profit growth of 24% signals a reacceleration in earnings after a sluggish 3-year CAGR of just 1%
  • 5-year compounded profit growth of 30% substantially outpaces 5-year sales growth of 11%, reflecting improving cost efficiency and pricing power
  • ROE has improved from a 10-year average of 11% to 14% in the last year, showing a trend of improving capital efficiency
  • TTM sales growth of 10% marks a recovery from the negative 3-year sales CAGR of -7%, suggesting a potential demand upturn
  • Backed by Linde plc, a global leader in industrial gases, providing access to proprietary technology, operational expertise, and long-term contracts
  • Consistent dividend payout ratio of 21.8% maintained despite cyclical revenue patterns, reflecting management's confidence in cash flow generation
Bear Case 8
  • PE ratio of 97.2x is extremely elevated relative to broader market and chemicals sector averages, leaving very little margin of safety
  • Price-to-book of 12.45x indicates the stock trades at a significant premium to its asset base, well above sector norms
  • 5-year sales CAGR of only 11% and 10-year sales CAGR of just 5% reflect structurally slow top-line growth for such a richly valued company
  • 3-year compounded sales growth is negative at -7%, indicating a meaningful period of revenue contraction
  • 3-year ROE of 13% is modest for a company commanding a near-100x PE multiple, suggesting limited return generation relative to valuation
  • Dividend yield of just 0.19% offers negligible income return, providing little downside cushion for investors
  • Stock CAGR of -3% over 1 year and only 1% over 3 years shows the market has already repriced the stock after its earlier rally, with 5-year CAGR moderating to 20%
  • 3-year profit CAGR of just 1% contrasts sharply with the 10-year figure of 41%, suggesting the high-growth phase may have already matured

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Positives 2
  • Strong PAT growth, dividend declared Sep 10

    Linde India reported a 23% jump in PAT for FY26 on revenue of ₹25,306 million (up 2% YoY). Shareholders approved a ₹12 per share dividend at the 90th AGM.

  • Gases business steady growth Sep 10

    The core Gases segment grew 4% in FY26, outpacing overall revenue growth and indicating healthy demand from industrial customers.

TL;DR: Linde India is delivering solid profit growth with PAT up 23% despite modest 2% revenue expansion, suggesting improving margins and operating leverage. The ₹12 dividend signals management confidence in cash flows. With only one recent news item available, visibility on risks is limited. The trend appears positive, but investors should watch whether the Gases segment can sustain mid-single-digit growth momentum.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
721
711
706
630
653
634
606
592
571
644
701
614
694
Expenses
557
538
520
452
469
456
414
382
374
362
444
441
494
Operating Profit
164
174
186
179
184
179
192
210
197
282
257
173
201
OPM %
23%
24%
26%
28%
28%
28%
32%
35%
34%
44%
37%
28%
29%
Other Income
18
19
22
18
19
16
19
13
4
4
53
6
6
Interest
1
1
1
4
2
2
2
7
3
3
6
3
6
Depreciation
49
50
51
52
51
52
55
56
56
56
62
61
62
PBT
132
141
156
141
150
141
155
161
142
226
243
115
138
Tax %
26%
24%
25%
26%
25%
26%
26%
27%
26%
25%
21%
26%
25%
Net Profit
98
107
117
104
112
104
114
118
105
169
192
85
103
EPS in Rs
11.51
12.51
13.74
12.23
13.08
12.24
13.37
13.82
12.32
19.82
22.46
9.99
12.08
Figures in ₹ Crores

Profit & Loss

Particulars Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Mar 2023 15mMar 2024Mar 2025Mar 2026TTM
Sales
1,491
1,567
1,825
2,033
2,192
1,762
1,471
2,112
3,136
2,769
2,485
2,531
2,654
Expenses
1,214
1,337
1,539
1,705
1,866
1,347
1,096
1,564
2,371
2,066
1,720
1,622
1,741
Operating Profit
277
230
287
328
326
415
375
548
765
702
765
909
913
OPM %
19%
15%
16%
16%
15%
24%
25%
26%
24%
25%
31%
36%
34%
Other Income
11
22
34
11
23
862
44
348
109
77
68
67
69
Interest
103
90
116
116
103
86
6
3
6
7
13
14
17
Depreciation
181
162
195
206
199
177
176
181
253
201
214
235
241
PBT
4
1
10
16
47
1,013
236
711
614
571
606
727
723
Tax %
-51%
-4164%
-31%
-17%
29%
28%
34%
28%
13%
25%
26%
24%
Net Profit
5
23
13
19
33
727
156
514
536
426
448
551
549
EPS in Rs
0.63
2.75
1.57
2.22
3.93
85.27
18.24
60.26
62.82
49.99
52.51
64.59
64.35
Div. Payout %
237%
27%
48%
45%
38%
12%
16%
22%
19%
24%
23%
19%
Figures in ₹ Crores

Balance Sheet

Particulars Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
85
85
85
85
85
85
85
85
85
85
85
85
Reserves
1,304
1,307
1,310
1,322
1,342
2,052
2,118
2,606
3,029
3,349
3,694
4,142
Borrowings
1,564
1,388
1,445
1,282
1,199
108
7
24
22
21
42
79
Other Liabilities
926
883
722
680
759
970
1,048
1,287
1,246
1,324
1,289
1,463
Total Liabilities
3,880
3,664
3,563
3,369
3,385
3,215
3,259
4,003
4,382
4,780
5,110
5,769
Fixed Assets
2,201
2,158
2,573
2,498
2,162
2,035
1,989
1,869
1,762
1,822
1,925
2,093
CWIP
356
577
80
36
44
53
17
68
225
483
975
1,343
Investments
15
15
15
15
0
0
2
2
16
27
42
43
Other Assets
1,308
915
895
821
1,179
1,127
1,251
2,064
2,378
2,448
2,168
2,291
Total Assets
3,880
3,664
3,563
3,369
3,385
3,215
3,259
4,003
4,382
4,780
5,110
5,769
Figures in ₹ Crores

Cash Flow

Particulars Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating
271
242
293
252
376
327
339
589
629
437
584
786
Investing
-264
-58
-128
-59
-73
981
-54
98
-306
-539
-1,305
-705
Financing
-8
-222
-80
-261
-216
-1,193
-201
-28
-119
-105
-112
-116
Net Cash Flow
-1
-37
85
-68
87
115
84
659
203
-208
-833
-35
Free Cash Flow
5
181
160
184
286
251
271
454
280
-127
-739
25
CFO/OP
106
101
104
79
118
82
98
121
107
84
101
109
Figures in ₹ Crores

Ratios

Particulars Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
75
78
71
63
61
79
101
73
47
63
57
73
Inventory Days
153
141
102
91
66
57
72
37
22
32
69
79
Days Payable
541
466
447
348
293
327
477
312
156
235
349
370
Cash Conversion Cycle
-313
-247
-274
-194
-166
-190
-303
-202
-87
-139
-224
-217
Working Capital Days
-81
16
-70
-69
-81
-22
6
-3
-9
-11
-29
-40
ROCE %
3%
3%
4%
5%
6%
11%
10%
17%
21%
17%
17%
18%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Linde insights

65 extracted metrics + investor summaries across FY03–FY26.

Log in — free

Shareholding Pattern

FIIs2.04%Promot.75.00%Others3.28%DIIs6.79%Public12.89%As ofJun 2026

Documents

Frequently Asked Questions about Linde

What does Linde India Ltd do?
Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]
Where is Linde India Ltd (LINDEINDIA) listed?
Linde India Ltd trades as LINDEINDIA on the NSE and under code 523457 on the BSE.
Which sector does Linde India Ltd belong to?
Linde India Ltd is classified under the Chemicals sector, in the Industrial Gases industry.
What is the market capitalisation of Linde India Ltd?
Linde India Ltd has a market capitalisation of ₹52,949 Cr, which places it in the Large Cap band.
What is the PE ratio of Linde India Ltd?
Linde India Ltd trades at a PE ratio of 96.78, on earnings per share of ₹52.52, against a book value of ₹500.3 per share.
What is the 52-week high and low of Linde India Ltd?
Over the last 52 weeks Linde India Ltd has traded between ₹5,673 and ₹8,049.
Does Linde India Ltd pay dividends?
Linde India Ltd has a dividend yield of 0.19%.
What is the Return on Equity (ROE) of Linde India Ltd?
Linde India Ltd reported a return on equity of 12.87%. Its debt-to-equity ratio is 0.02.

Company Information

Linde India Limited, a subsidiary of BOC Group,UK (owns 75% stake in the co), is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non cryogenic air separation plants.[1]

CEO Mr. Neeraj Kumar Jumrani
Employees 256
Listed 1999-06-16
Face Value ₹ 10
Issued Size 8,52,84,223

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LINDEINDIA.md for Linde India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More